[Cl:1][C:2]1[CH:15]=[CH:14][C:5]([CH2:6][N:7]2[CH2:12][CH2:11][CH:10]([NH2:13])[CH2:9][CH2:8]2)=[CH:4][C:3]=1[O:16][CH2:17][CH3:18].[C:19](O)(=[O:29])[C:20]1[CH:28]=[CH:27][CH:26]=[C:22]([C:23](N)=[O:24])[CH:21]=1>>[Cl:1][C:2]1[CH:15]=[CH:14][C:5]([CH2:6][N:7]2[CH2:12][CH2:11][CH:10]([N:13]3[C:23](=[O:24])[C:22]4=[CH:26][CH:27]=[CH:28][C:20](=[CH:21]4)[C:19]3=[O:29])[CH2:9][CH2:8]2)=[CH:4][C:3]=1[O:16][CH2:17][CH3:18]The title compound (20 mg, 48%) was prepared analogously to example 1 by coupling of 1-(4-chloro-3-ethoxy-benzyl)piperidin-4-ylamine with isophthalamic acid (Chem. Ber. 1910, 43, 3474). MS: 416.4 (MH+)